NeuroStar said today it won FDA clearance for its next-gen NeuroStar advanced therapy transcranial magnetic stimulation device. The Malvern, Penn.-based company touted the device, which is designed to treat individuals with major depressive disorder, as the only FDA cleared TMS treatment which can be delivered in under 19 minutes. “As a practicing psychiatrist, I see firsthand the […]
NeuroStar
NeuroStar launches real-world registry for TMS therapy in depression
Transcranial magnetic stimulation device developer NeuroStar said today it launched a real-world registry for patients with depression treated with TMS therapy, touting it as the largest registry of its kind to date. The registry looks to collect and analyze data from over 6,000 patients with major depressive disorder who have been treated with NeuroStar Advanced […]